Behavior of ethiologic agents of onychomycosis in a mycology reference laboratory (Medellín 1994-2003);Comportamiento de los agentes etiológicos de las onicomicosis en un laboratorio de micologia de referencia (Medellín 1994-2003)

Medicina Cutanea Ibero-Latino-Americana

Volumn 33, Issue 6, 2005, Pages 251-256

  Zuluaga De C, Angela ^a,d   De Bedout, Catalina ^b   Tabares, Angela ^b   Cano, Luz Elena ^b   Restrepo, Angela ^b   Arango, Myrta ^b,c   Manrique, Ruben ^a  

^a UNIVERSIDAD CES   (Colombia)

^b Unidad de Biología Celular y Molecular   (Colombia)

^c UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^d Clínica Las Vegas Fase II Consultorio   (Colombia)

Author keywords

Candida; Dermatophytes; Molds; Onychomycosis

Indexed keywords

ADULT; ARTICLE; CANDIDA ALBICANS; CANDIDA GUILLIERMONDII; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; FEMALE; FINGERNAIL ONYCHOMYCOSIS; FUSARIUM; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MORBIDITY; PATHOGENESIS; TOENAIL ONYCHOMYCOSIS;

EID: 42649118790     PISSN: 02105187     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Ghannoum MA, Hajjeh RA, Scher R, et al. A large-scale north american study of fungal isolates from nails: the frecuency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol 2000;43:641-8.
2. Gill D Marks RA review of the epidemiology of tinea unguium in the comunity. Austral J Dermatol 1999;40:6-13.
3. Rinaldi MG. Dermatophytosis: epidemiological and microbiological update. J Am Acad Dermatol 2000;43:120-4.
4. Midgley G, Moore MK, Cook JC, et al. Mycology of nail disorders. J Am Acad Dermatol 1994;31:68-74.
5. Zuluaga A, Tabares A M, Arango M, et al. Importancia creciente de los géneros Fusarium y Scytalidium como agentes de onicomicosis. Rev Asoc Col Dermat 2001;9:593-9.
6. Escobar ML. Carmona-Fonseca J. Onicomicosis por hongos ambientales no dermatofíticos. Rev Iberoam Micol. 2003;20:6-10.
7. Elewski BE. Onychomycosis: patogénesis, diagnosis and management. Clin Microbiol Rev 1997;11:415-29.
8. Haneke E Roseeuw D. The scope of onychomycosis: epidemiology and clinical features. I J Dermatol 1999;38(Suppl.2):7-12.
9. Gupta AK, Jain HC, Lynde CW et al. Prevalence and epidemiology of onychomycosis in visiting physicians' offices: A multicenter Canadian survey of 15,000 patients. J AM Acad Dermatol 2000;43:244-8.
10. Jain S and Sehgal VN. Onychomycosis: an epidemio-etiologic perspective. Int J Dermatol 2000;39:100-3.
11. Faergemann J and Baran R. Epidemiology, clinical presentation and diagnosis of onychomycosis. Br J Dermatol 2003;149(Suppl 65):1-4.
12. Alvarez MI, González LA Castro LA. Onychomycosis in Cali, Colombia. Mycopathologia 2004;158:181-6.
13. Gupta AK, Ryder Je and Summerbell RC. The diagnosis of nondermatophyte mold onycchomycosis. Int J Dermatol 2003;42:272-3.
14. Williams HC. The epidemiology of onychomycosis in Britain. Br J Dermat 1993;129:101-9.
15. Padilla M del C and Bengoa B. Onicomicosis por mohos. Dermatología Rev Mex 2004;48:237-41.
16. De Bedout C, Tabares A, Restrepo A et al. Especies de Candida aisladas de lesions ungueales y su sensibilidad in vitro al fluconazol (1999-2001). Rev A Col Dermatol 2003;11:325-31.
17. De Vroey C, Desmet P, Mukamurangwa ZQ. Li.P et al. Further studies on the in vitro antifungal activity of amorolfine. Mycoses 1996;36:41-4.